Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Visiomed Group buy melinda

Visiomed Group
Start price
€13.26
02.08.18 / 50%
Target price
€18.00
18.12.18
Performance (%)
-74.21%
End price
€3.42
18.12.18
Summary
This prediction ended on 18.12.18 with a price of €3.42. The BUY prediction by melinda for Visiomed Group performed very badly with a performance of -74.21%. melinda has a follow-up prediction for Visiomed Group where he still thinks Visiomed Group is a Buy. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Visiomed Group -6.111% -6.111% -56.104% -60.440%
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

According to melinda what are the pros and cons of Visiomed Group for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Visiomed Group diskutieren
Prediction Buy
Perf. (%) -74.21%
Target price 0.450
Change
Ends at 18.12.18

santé



A suivre aujourd'hui... VISIOMED
AOF 10.07.201808:02

(AOF) - Visiomed Group annonce que les Laboratoires Visiomed, branche dédiée aux produits de santé familiale commercialisés en pharmacie, vient de signer un projet d'acquisition de « deux marques centenaires leader en pharmacies dans leur domaine ». Ces marques, qui ne sont pas nommées, étaient détenues jusqu'à présent par les laboratoires Omega Pharma France et les Laboratoires Omega Pharma Belgium, filiales du groupe pharmaceutique américain Perrigo



melinda 
0
Report Share
02.08.18
Prediction Buy
Perf. (%) -74.21%
Target price 0.450
Change
Ends at 18.12.18

(Vom Mitglied beendet)

melinda 
0
Report Share
18.12.18

Current prediction by melinda for Visiomed Group

buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.25
02.11.23
€0.50
02.11.24
-32.45%
02.05.24

Could be worthwhile Investment >10% per year
melinda 
02.11.23 20%

Stopped prediction by melinda for Visiomed Group

buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
melinda 
24.01.22 20%
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%